2023
Acceptability of 4-poster deer treatment devices for community-wide tick control among residents of high Lyme disease incidence counties in Connecticut and New York, USA
Nawrocki C, Piedmonte N, Niesobecki S, Rowe A, Hansen A, Kaufman A, Foster E, Meek J, Niccolai L, White J, Backenson B, Eisen L, Hook S, Connally N, Hornbostel V, Hinckley A. Acceptability of 4-poster deer treatment devices for community-wide tick control among residents of high Lyme disease incidence counties in Connecticut and New York, USA. Ticks And Tick-borne Diseases 2023, 14: 102231. PMID: 37531890, PMCID: PMC10883357, DOI: 10.1016/j.ttbdis.2023.102231.Peer-Reviewed Original Research
2022
Changes in the microbiology, epidemiology, and outcomes of candidemia in Connecticut: A comparison between two periods using statewide surveillance
Gleason-Vergados J, Clogher P, Meek J, Banach D. Changes in the microbiology, epidemiology, and outcomes of candidemia in Connecticut: A comparison between two periods using statewide surveillance. Infection Control And Hospital Epidemiology 2022, 44: 994-996. PMID: 36004535, DOI: 10.1017/ice.2022.38.Peer-Reviewed Original ResearchMeSH KeywordsAntifungal AgentsCandidaCandidemiaConnecticutHospital MortalityHumansRetrospective StudiesRisk Factors
2021
Evaluating public acceptability of a potential Lyme disease vaccine using a population-based, cross-sectional survey in high incidence areas of the United States
Hook SA, Hansen AP, Niesobecki SA, Meek JI, Bjork JKH, Kough EM, Peterson MS, Schiffman EK, Rutz HJ, Rowe AJ, White JL, Peel JL, Biggerstaff BJ, Hinckley AF. Evaluating public acceptability of a potential Lyme disease vaccine using a population-based, cross-sectional survey in high incidence areas of the United States. Vaccine 2021, 40: 298-305. PMID: 34895785, DOI: 10.1016/j.vaccine.2021.11.065.Peer-Reviewed Original ResearchConceptsLyme disease vaccineDisease vaccineSurvey-weighted descriptive statisticsMultivariable multinomial logistic regression modelsCross-sectional studyLyme disease incidenceHigh incidence areaCross-sectional surveyLogistic regression modelsSafety concernsMultinomial logistic regression modelsVaccine uptakeAdults 45Vaccine parametersVaccine candidatesVaccine attitudesPrevention optionsHealthcare providersWeb-based surveyVaccineSociodemographic characteristicsIncidence areaLyme diseaseDisease incidenceIncidenceTrends in Precancerous Cervical Lesions by Area-Based Measures of Poverty, Race, and Ethnicity, Connecticut, 2008-2018
Brackney MM, Weinberger DM, Higgins K, Meek J, Niccolai LM. Trends in Precancerous Cervical Lesions by Area-Based Measures of Poverty, Race, and Ethnicity, Connecticut, 2008-2018. Public Health Reports 2021, 137: 1146-1152. PMID: 34727517, PMCID: PMC9574305, DOI: 10.1177/00333549211056300.Peer-Reviewed Original ResearchConceptsPrecancerous cervical lesionsAverage annual percentage changeCervical lesionsArea-based measuresPublic Health Disparities Geocoding ProjectAge groupsHuman papillomavirus vaccinationJoinpoint regression softwareAnnual percentage changeActive surveillance systemHPV vaccinationPapillomavirus vaccinationBody of evidenceIncidence rateSociodemographic characteristicsLesionsYoung womenAnnual declineIncidence dataPercentage changeCut pointsWomenVaccinationCensus tract levelSurveillance systemPrevention of Lyme and other tickborne diseases using a rodent‐targeted approach: A randomized controlled trial in Connecticut
Hinckley A, Niesobecki S, Connally N, Hook S, Biggerstaff B, Horiuchi K, Hojgaard A, Mead P, Meek J. Prevention of Lyme and other tickborne diseases using a rodent‐targeted approach: A randomized controlled trial in Connecticut. Zoonoses And Public Health 2021, 68: 578-587. PMID: 34050628, PMCID: PMC10898493, DOI: 10.1111/zph.12844.Peer-Reviewed Original ResearchMeSH KeywordsAnimalsAntiparasitic AgentsConnecticutHumansIxodesLyme DiseasePyrazolesRodentiaTick InfestationsConceptsTickborne diseasesTreatment groupsInfection ratePlacebo-controlled trialPublic health problemTick encountersIxodes scapularis ticksTick exposureHousehold membersHealth problemsPathogen infection ratesDiseaseScapularis ticksSignificant differencesNymphal ticksTransmission cycleTrialsEnzootic cycleInterventionPathogen transmission cyclesBait boxesBiannual surveysGroupTicksYearsHuman‐tick encounters as a measure of tickborne disease risk in lyme disease endemic areas
Hook S, Nawrocki C, Meek J, Feldman K, White J, Connally N, Hinckley A. Human‐tick encounters as a measure of tickborne disease risk in lyme disease endemic areas. Zoonoses And Public Health 2021, 68: 384-392. PMID: 33554467, PMCID: PMC10883354, DOI: 10.1111/zph.12810.Peer-Reviewed Original ResearchMeSH KeywordsAnimalsArachnid VectorsConnecticutHumansLyme DiseaseMarylandNew YorkRisk FactorsTick BitesTicks
2020
Community Trace: Rapid Establishment of a Volunteer Contact Tracing Program for COVID-19.
Niccolai L, Shelby T, Weeks B, Schenck C, Goodwin J, Hennein R, Rossini M, Vazquez J, van Rhijn D, Meek J, Bond M. Community Trace: Rapid Establishment of a Volunteer Contact Tracing Program for COVID-19. American Journal Of Public Health 2020, 111: 54-57. PMID: 33211580, PMCID: PMC7750620, DOI: 10.2105/ajph.2020.305959.Peer-Reviewed Original ResearchHuman Papillomavirus 16/18–Associated Cervical Lesions: Differences by Area-Based Measures of Race and Poverty
Brackney MM, Gargano JW, Hannagan SE, Meek J, Querec TD, Niccolai LM. Human Papillomavirus 16/18–Associated Cervical Lesions: Differences by Area-Based Measures of Race and Poverty. American Journal Of Preventive Medicine 2020, 58: e149-e157. PMID: 32001053, DOI: 10.1016/j.amepre.2019.12.003.Peer-Reviewed Original ResearchConceptsHuman papillomavirus 16/18Area-based measuresProportion of lesionsCervical lesionsMultivariable logistic regression modelingHuman papillomavirus vaccineLogistic regression modelingPapillomavirus vaccineHuman papillomavirusInsurance statusNew Haven CountyHealth outcomesCensus tract characteristicsSociodemographic characteristicsLesionsIndependent effectsRegression modelingWomenEarly declineSignificant declineEthnicity
2019
Knowledge, attitudes, and behaviors regarding tick-borne disease prevention in endemic areas
Niesobecki S, Hansen A, Rutz H, Mehta S, Feldman K, Meek J, Niccolai L, Hook S, Hinckley A. Knowledge, attitudes, and behaviors regarding tick-borne disease prevention in endemic areas. Ticks And Tick-borne Diseases 2019, 10: 101264. PMID: 31431351, PMCID: PMC10948045, DOI: 10.1016/j.ttbdis.2019.07.008.Peer-Reviewed Original ResearchConceptsEndemic areasPrevalence of LDPrevention behaviorsShowering/bathingTick checksDisease preventionPerceived PrevalenceLyme disease vaccineLD endemic areasInsect repellentSelf-rated knowledgeUnadjusted analysesOdds ratioMultivariable modelFemale genderLD vaccineDisease vaccinePrevention optionsLocal prevalencePreventive behaviorsSociodemographic characteristicsPrevalenceMajority of respondentsOnly factorTick controlMissed Opportunities for HPV Vaccination Among Vaccine-Eligible Women with High Grade Cervical Lesions
Russ SM, Brackney M, Meek J, Niccolai LM. Missed Opportunities for HPV Vaccination Among Vaccine-Eligible Women with High Grade Cervical Lesions. Vaccine 2019, 37: 4262-4267. PMID: 31248688, DOI: 10.1016/j.vaccine.2019.06.061.Peer-Reviewed Original ResearchConceptsHigh-grade cervical lesionsVaccine-eligible womenHPV vaccinationHPV diagnosisProvider recommendationCervical lesionsLog-binomial analysisHuman papillomavirus vaccineCervical intraepithelial neoplasiaStatewide surveillance systemCochran-Armitage trend testSelf-reported barriersArmitage trend testEligible patientsChart reviewHPV vaccinePapillomavirus vaccineVaccination statusCIN 2Intraepithelial neoplasiaVaccine eligibilityPatient interviewsVaccine historyNew Haven CountyVaccination
2017
Risk factors for tick exposure in suburban settings in the Northeastern United States
Mead P, Hook S, Niesobecki S, Ray J, Meek J, Delorey M, Prue C, Hinckley A. Risk factors for tick exposure in suburban settings in the Northeastern United States. Ticks And Tick-borne Diseases 2017, 9: 319-324. PMID: 29174449, DOI: 10.1016/j.ttbdis.2017.11.006.Peer-Reviewed Original ResearchDeclines in Human Papillomavirus (HPV)–Associated High-Grade Cervical Lesions After Introduction of HPV Vaccines in Connecticut, United States, 2008–2015
Niccolai LM, Meek JI, Brackney M, Hadler JL, Sosa LE, Weinberger DM. Declines in Human Papillomavirus (HPV)–Associated High-Grade Cervical Lesions After Introduction of HPV Vaccines in Connecticut, United States, 2008–2015. Clinical Infectious Diseases 2017, 65: 884-889. PMID: 28520854, DOI: 10.1093/cid/cix455.Peer-Reviewed Original ResearchConceptsCervical cancer screeningCervical lesionsRisk behaviorsHPV vaccinationVaccination coverageHuman papillomavirusCancer screeningBirth cohortHigh-grade cervical lesionsHPV vaccination coverageRates of CIN2Cervical intraepithelial neoplasiaHigh-grade lesionsSexual risk behaviorsSignificant declineHPV vaccineVaccine impactIntraepithelial neoplasiaCervical cancerRisk factorsSurveillance periodSimilar epidemiologyChlamydia trachomatisCohort patternsNegative binomial regression
2015
Identification of population at risk for future Clostridium difficile infection following hospital discharge to be targeted for vaccine trials
Baggs J, Yousey-Hindes K, Ashley ED, Meek J, Dumyati G, Cohen J, Wise ME, McDonald LC, Lessa FC. Identification of population at risk for future Clostridium difficile infection following hospital discharge to be targeted for vaccine trials. Vaccine 2015, 33: 6241-6249. PMID: 26450660, PMCID: PMC4702247, DOI: 10.1016/j.vaccine.2015.09.078.Peer-Reviewed Original ResearchConceptsEmerging Infections ProgramHigh-risk groupRisk groupsRisk scoreIndex hospitalizationHospital dischargeDerivation cohortVaccine trialsValidation cohortDifficile infectionCox proportional hazards modelRisk of CDIAcute care hospitalizationIdentification of patientsClostridium difficile infectionHospital discharge dataNumber of hospitalizationsLow-risk groupProportional hazards modelLarge academic centerAdmission diagnosisPrimary outcomeInpatient stayPatient populationPharmacy data
2013
Declining Rates of High-Grade Cervical Lesions in Young Women in Connecticut, 2008–2011
Niccolai LM, Julian PJ, Meek JI, McBride V, Hadler JL, Sosa LE. Declining Rates of High-Grade Cervical Lesions in Young Women in Connecticut, 2008–2011. Cancer Epidemiology Biomarkers & Prevention 2013, 22: 1446-1450. PMID: 23704476, DOI: 10.1158/1055-9965.epi-13-0272.Peer-Reviewed Original ResearchConceptsHigh-grade cervical lesionsCervical lesionsVaccine impactAge 21Young womenEarly vaccine impactHPV vaccine initiationCervical intraepithelial neoplasiaHuman papillomavirus type 16Women ages 21Women age 25Papillomavirus type 16Federal poverty levelCensus tract measuresFemales ages 21Vaccine initiationHPV vaccineIntraepithelial neoplasiaSurveillance registryCervical cancerCervical neoplasiaContinued surveillanceType 16Health disparitiesAge 25Selection of Neighborhood Controls for a Population-Based Lyme Disease Case-Control Study by Using a Commercial Marketing Database
Connally NP, Yousey-Hindes K, Meek J. Selection of Neighborhood Controls for a Population-Based Lyme Disease Case-Control Study by Using a Commercial Marketing Database. American Journal Of Epidemiology 2013, 178: 276-279. PMID: 23696105, DOI: 10.1093/aje/kws464.Peer-Reviewed Original ResearchIndividual and geographic disparities in human papillomavirus types 16/18 in high‐grade cervical lesions
Niccolai LM, Russ C, Julian PJ, Hariri S, Sinard J, Meek JI, McBride V, Markowitz LE, Unger ER, Hadler JL, Sosa LE. Individual and geographic disparities in human papillomavirus types 16/18 in high‐grade cervical lesions. Cancer 2013, 119: 3052-3058. PMID: 23661284, DOI: 10.1002/cncr.28038.Peer-Reviewed Original Research
2012
Geographic poverty and racial/ethnic disparities in cervical cancer precursor rates in Connecticut, 2008-2009.
Niccolai LM, Julian PJ, Bilinski A, Mehta NR, Meek JI, Zelterman D, Hadler JL, Sosa L. Geographic poverty and racial/ethnic disparities in cervical cancer precursor rates in Connecticut, 2008-2009. American Journal Of Public Health 2012, 103: 156-63. PMID: 22515856, PMCID: PMC3518345, DOI: 10.2105/ajph.2011.300447.Peer-Reviewed Original ResearchConceptsCervical intraepithelial neoplasia grade 2Human papillomavirus (HPV) vaccine impactStatewide surveillance dataCervical cancer precursorsAge-specific ratesVaccine impactCervical cancerCancer precursorsInverse associationVaccination strategiesGeographic measuresGrade 2Poisson regressionEthnic disparitiesSurveillance dataWomenHuman Papillomavirus Vaccination History Among Women With Precancerous Cervical Lesions
Mehta NR, Julian PJ, Meek JI, Sosa LE, Bilinski A, Hariri S, Markowitz LE, Hadler JL, Niccolai LM. Human Papillomavirus Vaccination History Among Women With Precancerous Cervical Lesions. Obstetrics And Gynecology 2012, 119: 575-581. PMID: 22353956, DOI: 10.1097/aog.0b013e3182460d9f.Peer-Reviewed Original ResearchConceptsHuman papillomavirus vaccination historyAbnormal cytology resultsPrecancerous cervical lesionsCervical lesionsHPV vaccineVaccination historyCytology resultsHigh-grade cervical lesionsPrivate insuranceMedical record reviewTiming of vaccinationHistory of vaccinationPublic health surveillanceAfrican American womenUnvaccinated womenUninsured womenRecord reviewSurveillance registryMore dosesMean ageProvider recommendationVaccination strategiesVaccinationHealth surveillanceLesions
2011
Leveraging State Immunization Information Systems to Measure the Effectiveness of Rotavirus Vaccine
Cortese M, LeBlanc J, White K, Jerris R, Stinchfield P, Preston K, Meek J, Odofin L, Khizer S, Miller C, Buttery V, Mijatovic-Rustempasic S, Lewis J, Parashar U, Immergluck L. Leveraging State Immunization Information Systems to Measure the Effectiveness of Rotavirus Vaccine. Pediatrics 2011, 128: e1474-e1481. PMID: 22084328, PMCID: PMC8202521, DOI: 10.1542/peds.2011-1006.Peer-Reviewed Original ResearchConceptsImmunization Information SystemVaccine effectivenessControl groupState Immunization Information SystemRotavirus vaccine effectivenessRotavirus-negative controlsVaccine-eligible childrenEffectiveness of vaccinesVE point estimatesCase-control methodologyYears of lifeRotavirus diseaseRotavirus vaccineNegative childrenEmergency departmentRotavirus seasonRotavirus antigenImmunization recordsEligibility criteriaUS childrenImmunization dataMonthsDosesZip codesChildrenClostridium difficile Infection in Outpatients, Maryland and Connecticut, USA, 2002–2007 - Volume 17, Number 10—October 2011 - Emerging Infectious Diseases journal - CDC
Hirshon JM, Thompson AD, Limbago B, McDonald LC, Bonkosky M, Heimer R, Meek J, Mai V, Braden C. Clostridium difficile Infection in Outpatients, Maryland and Connecticut, USA, 2002–2007 - Volume 17, Number 10—October 2011 - Emerging Infectious Diseases journal - CDC. Emerging Infectious Diseases 2011, 17: 1946-1949. PMID: 22000379, PMCID: PMC3310666, DOI: 10.3201/eid1710.110069.Peer-Reviewed Original Research